340B Drug Pricing Program
New Analysis Shows 340B Tax-exempt Hospitals Provided More Than $64B in Benefits to Communities
AHA seeks rehearing of U.S. appeals court decision on cuts to 340B hospitals
The AHA and other national health care groups yesterday urged the Department of Health and Human Services to protect 340B hospitals and the vulnerable communities they serve “from actions taken by five of the nation’s largest pharmaceutical manufacturers that undermine access to critical drugs and…
The AHA today sent letters to the heads of U.S.
The Department of Health and Human Services in a strongly worded letter to Eli Lilly calls into question recent actions by the drug manufacturer to limit 340B hospital and community clinics’ use of 340B contract pharmacy arrangements.
AHA 340B Advocacy Alliance Member Only Webinar September 16, 2020
Improving the health of their communities is at the heart of every hospital’s mission. As one example, in a new analysis released, the American Hospital Association (AHA) found that 340B tax-exempt hospitals provided more than $64.3 billion in total benefits to their communities in 2017 alone, the…
Improving the health of their communities is at the heart of every hospital’s mission. Tax-exempt hospitals are required to publicly report on the ways in which they improve the health of the communities they serve yearly through the IRS Form 990 Schedule H, which is publicly available.
In response to recent actions taken by a number of drug companies to limit the distribution of certain 340B drugs to hospitals and health systems, Reps. Diana DeGette, D-Colo., and David McKinley, R-W.Va., along with Reps. Peter Welch, D-Vt., Greg Gianforte, R-Mont., Dusty Johnson, R-S.D., and…
The AHA again expressed concern to the Department of Health and Human Services about recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to hospitals.